Ondine Biomedical Inc. (AIM: OBI)

Ondine Biomedical Revenue

Ondine Biomedical had revenue of 859.00K CAD in the half year ending June 30, 2024, with 227.86% growth. This brings the company's revenue in the last twelve months to 1.63M, up 103.23% year-over-year. In the year 2023, Ondine Biomedical had annual revenue of 1.20M with 88.56% growth.

• Revenue (ttm): 1.63M CAD
• Revenue Growth: +103.23%
• P/S Ratio: 25.68
• Revenue / Employee: 90.78K CAD
• Employees: 18
• Market Cap: 44.70M GBP

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	1.20M	565.00K	88.56%
Dec 31, 2022	638.00K	-1.93M	-75.17%
Dec 31, 2021	2.57M	778.00K	43.44%
Dec 31, 2020	1.79M	258.16K	16.84%
Dec 31, 2010	1.53M	502.61K	48.79%